Page last updated: 2024-08-23

fosinopril and enalapril

fosinopril has been researched along with enalapril in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (9.52)	18.7374
1990's	19 (45.24)	18.2507
2000's	10 (23.81)	29.6817
2010's	9 (21.43)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cutler, RE; Ford, NF; Parmer, RJ; Sica, DA	1
Aber, GM; Harding, P; Stonier, C	2
Barnes, NM; Costall, B; Egli, P; Horovitz, ZP; Ironside, JW; Naylor, RJ; Williams, TJ	1
Cushman, DW; DeForrest, JM; Fung, WC; Grover, GJ; Harvey, CM; Mitch, SL; Scalese, RJ; Wang, FL	1
Amidon, GL; Friedman, DI	1
Alpaugh, WC; Stauber, KL; Swanson, BN; Weinstein, SH	1
Cushman, DW; Ondetti, MA; Petrillo, EW; Powell, JR	1
Bastani, B; Redington, J	1
Frohlich, ED; Grossman, E; Oren, S	1
Hess, E; Sperschneider, H; Stein, G	1
Aärynen, M; Forslund, T; Hansson, L; Höglund, C; Istad, H; Kjellström, T; Kristinsson, A; Lederballe-Pedersen, O; Segaard, E; Svensson, A; Wahrenberg, H; Wennersten, G	1
Mancia, G; Omboni, S; Ravogli, A; Villani, A	1
Born, J; Derad, I; Fehm, HL; Mölle, M; Otterbein, A; Pietrowsky, R	1
Anderssson, PE; Berglund, L; Haenni, A; Lind, L; Lithell, H; Reneland, R	1
Benzie, IF; Tomlinson, B	1
Furberg, CD; Pahor, M; Psaty, BM	1
Chati, Z; Guest, M; Plat, F; Zannad, F	1
Pahor, M; Tatti, P	1
Akarawut, W; Lin, CJ; Smith, DE	1
Lee, AF; MacFadyen, RJ; Morton, JJ; Pringle, SD; Struthers, AD	1
Aĭrapetian, G; Ter-Grigorian, V	1
Birkenhäger, WH; Fagard, RH; Staessen, JA	1
Cukon, S; Ennezat, PV; Hammer, A; Infeld, J; Jorde, UP; Le Jemtel, TH; Lisker, J; Sonnenblick, EH; Suryadevara, V	1
Gallardo, J; García-Robles, R; Rodríguez-García, JL; Serrano, M; Villa, E	1
Bicket, DP	1
Bartels, T; Dominiak, P; Häuser, W; Raasch, W; Rütten, H; Schwartz, C	1
Gardiner, G; Guindi, M; Joshi, S; Shiota, K; Wanless, IR; Wong, FS; Yeung, E	1
Babar, S; Ducobu, J; Legssyer, I; Moguilevsky, N; Moreau, P; Nève, J; Van Antwerpen, P; Vanhaeverbeek, M; Zouaoui Boudjeltia, K	1
Chen, JL; Gao, RL; Pei, WD; Sun, YH; Yang, YJ; Zhang, YH; Zhao, JL	1
Abd-Alaty, NM; Baraka, MM; El-Sadek, M; Moussa, EM	1
Chou, J; Debanne, SM; Fang, JC; Mishra, P; Simon, DI; Sipahi, I	1
Citraro, R; Gallelli, L; Gareri, P; Gratteri, S; Paola, ED; Rispoli, V; Russo, E; Sarro, GD; Siniscalchi, A; Tripepi, G	1
Fish, BL; Gao, F; Jacobs, ER; Kma, L; Medhora, M; Moulder, JE	1
Cohen, EP; Fish, BL; Moulder, JE	1
Bezruchko, BP; Gridnev, VI; Karavaev, AS; Kiselev, AR; Ponomarenko, VI; Posnenkova, OM; Prokhorov, MD	1
Dixon, SN; Fleet, JL; Garg, AX; Jain, AK; McIntyre, C; Oliver, M; Wald, R; Weir, MA	1
Abbenante, G; Fairlie, DP; Leung, D	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1

Reviews

6 review(s) available for fosinopril and enalapril

Article	Year
Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients. European heart journal, 2000, Volume: 21, Issue:1 Topics: Amlodipine; Calcium Channel Blockers; Diabetic Angiopathies; Dihydropyridines; Enalapril; Fosinopril; Humans; Hypertension; Randomized Controlled Trials as Topic	2000
Using ACE inhibitors appropriately. American family physician, 2002, Aug-01, Volume: 66, Issue:3 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States	2002
Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk. The American journal of cardiology, 2011, Jul-15, Volume: 108, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Enalapril; Fosinopril; Humans; Lisinopril; Neoplasms; Quinapril; Ramipril; Randomized Controlled Trials as Topic; Tetrahydroisoquinolines	2011
Protease inhibitors: current status and future prospects. Journal of medicinal chemistry, 2000, Feb-10, Volume: 43, Issue:3 Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors	2000
Membrane transporters in drug development. Nature reviews. Drug discovery, 2010, Volume: 9, Issue:3 Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs	2010
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

7 trial(s) available for fosinopril and enalapril

Article	Year
Fosinopril versus enalapril in the treatment of hypertension: a double-blind study in 195 patients. Journal of cardiovascular pharmacology, 1996, Volume: 28, Issue:1 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Enalapril; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged	1996
Permanent blood pressure control over the 24 h by trandolapril. American journal of hypertension, 1995, Volume: 8, Issue:10 Pt 2 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Enalapril; Fosinopril; Humans; Hypertension; Indoles; Middle Aged	1995
The angiotensin converting enzyme inhibitors fosinopril and enalapril differ in their central nervous effects in humans. Journal of hypertension, 1996, Volume: 14, Issue:11 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Brain; Catecholamines; Double-Blind Method; Enalapril; Evoked Potentials; Fosinopril; Heart Rate; Humans; Male	1996
The alterations in insulin sensitivity during angiotensin converting enzyme inhibitor treatment are related to changes in the calcium/magnesium balance. American journal of hypertension, 1997, Volume: 10, Issue:2 Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium; Captopril; Double-Blind Method; Enalapril; Female; Fosinopril; Humans; Hypertension; Insulin; Lisinopril; Magnesium; Male; Middle Aged	1997
Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failure. Fosinopril in Heart Failure Study Investigators. American heart journal, 1998, Volume: 136, Issue:4 Pt 1 Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Disease-Free Survival; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Female; Fosinopril; France; Heart Failure; Humans; Male; Middle Aged; Treatment Outcome	1998
The Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET) and combination therapies. The American journal of cardiology, 1999, Mar-01, Volume: 83, Issue:5 Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Drug Combinations; Enalapril; Follow-Up Studies; Fosinopril; Heart Diseases; Humans; Hypertension; Nisoldipine; Prospective Studies; Reproducibility of Results; Risk Factors; Treatment Outcome	1999
Prostacyclin: its pathogenic role in essential hypertension and the class effect of ACE inhibitors on prostaglandin metabolism. Blood pressure, 1999, Volume: 8, Issue:5-6 Topics: 6-Ketoprostaglandin F1 alpha; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Case-Control Studies; Enalapril; Epoprostenol; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Prostaglandins; Ramipril	1999

Other Studies

29 other study(ies) available for fosinopril and enalapril

Article	Year
Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency. Clinical pharmacokinetics, 1991, Volume: 20, Issue:5 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Female; Fosinopril; Humans; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Proline	1991
Effect of angiotensin-converting enzyme inhibitors on glomerular eicosanoid production in normotensive and spontaneously hypertensive rats. Clinical science (London, England : 1979), 1991, Volume: 81, Issue:4 Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Culture Techniques; Dinoprostone; Eicosanoids; Enalapril; Fosinopril; Hypertension; Kidney Glomerulus; Male; Proline; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thromboxane A2	1991
Characterisation of [3H]ceranapril recognition sites in rat and human brain tissue. Neuropharmacology, 1991, Volume: 30, Issue:8 Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Brain; Captopril; Enalapril; Female; Fosinopril; Humans; Kinetics; Lisinopril; Male; Middle Aged; Organophosphorus Compounds; Proline; Rats; Thiorphan	1991
Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE). British journal of clinical pharmacology, 1989, Volume: 28 Suppl 2 Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Chemotherapy, Cancer, Regional Perfusion; Dose-Response Relationship, Drug; Enalapril; Fosinopril; Heart; Hypertension; Lisinopril; Male; Organophosphorus Compounds; Proline; Ramipril; Rats; Time Factors; Tissue Distribution	1989
Passive and carrier-mediated intestinal absorption components of two angiotensin converting enzyme (ACE) inhibitor prodrugs in rats: enalapril and fosinopril. Pharmaceutical research, 1989, Volume: 6, Issue:12 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Chromatography, High Pressure Liquid; Enalapril; Fosinopril; Hydrolysis; Intestinal Absorption; Jejunum; Perfusion; Permeability; Prodrugs; Proline; Rats; Scintillation Counting	1989
Radioenzymatic assay of angiotensin-converting enzyme inhibitors in plasma and urine. Analytical biochemistry, 1985, Aug-01, Volume: 148, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biological Availability; Dogs; Enalapril; Enalaprilat; Fosinopril; Haplorhini; Hydrolysis; Male; Proline; Rats	1985
Angiotensin-converting enzyme inhibitors: accomplishments and challenges. Clinical and experimental hypertension. Part A, Theory and practice, 1987, Volume: 9, Issue:2-3 Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Chemical Phenomena; Chemistry; Enalapril; Fosinopril; Humans; Proline	1987
Lack of efficacy of angiotensin-converting enzyme inhibitors in reducing interdialytic weight gain. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1994, Volume: 24, Issue:6 Topics: Angiotensin-Converting Enzyme Inhibitors; Black People; Captopril; Enalapril; Fosinopril; Humans; Hypertension; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Retrospective Studies; Weight Gain	1994
Dose-dependent effects of angiotensin converting enzyme (ACE) inhibitors on glomerular prostanoid production by normotensive rats. British journal of pharmacology, 1993, Volume: 108, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Enalapril; Fosinopril; In Vitro Techniques; Kidney Glomerulus; Male; Prostaglandins; Rats; Rats, Inbred WKY; Reference Values	1993
Reduction in left ventricular mass in patients with systemic hypertension treated with enalapril, lisinopril, or fosenopril. The American journal of cardiology, 1996, Jan-01, Volume: 77, Issue:1 Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Enalapril; Female; Fosinopril; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Male; Middle Aged; Ventricular Function, Left	1996
Do ACE inhibitors influence the dose of human recombinant erythropoietin in dialysis patients? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996, Volume: 11, Issue:4 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Enalapril; Erythropoietin; Female; Follow-Up Studies; Fosinopril; Hematocrit; Humans; Hypertension; Kidney Failure, Chronic; Male; Recombinant Proteins; Renal Dialysis; Retrospective Studies	1996
Antioxidant power of angiotensin-converting enzyme inhibitors in vitro. British journal of clinical pharmacology, 1998, Volume: 45, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Captopril; Colorimetry; Dose-Response Relationship, Drug; Enalapril; Ferric Compounds; Ferrous Compounds; Fosinopril; Indoles; Isoquinolines; Oxidation-Reduction; Perindopril; Quinapril; Tetrahydroisoquinolines	1998
Treatment of hypertensive patients with diabetes. Lancet (London, England), 1998, Mar-07, Volume: 351, Issue:9104 Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Case-Control Studies; Cohort Studies; Diabetes Complications; Enalapril; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Nisoldipine; Randomized Controlled Trials as Topic	1998
Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter. Pharmaceutical research, 1999, Volume: 16, Issue:5 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Binding, Competitive; Captopril; Carrier Proteins; Cell Membrane; Dipeptides; Dose-Response Relationship, Drug; Enalapril; Fosinopril; Isoquinolines; Kidney; Kinetics; Lipid Metabolism; Lipids; Lisinopril; Male; Microvilli; Peptide Transporter 1; Quinapril; Rabbits; Ramipril; Symporters; Tetrahydroisoquinolines	1999
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure? Heart (British Cardiac Society), 1999, Volume: 82, Issue:1 Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Enalapril; Female; Fosinopril; Heart Failure; Humans; Indoles; Lisinopril; Male; Peptidyl-Dipeptidase A; Perindopril; Treatment Failure	1999
[Early application of angiotensin converting enzyme inhibitors in acute myocardial infarction]. Klinicheskaia meditsina, 1999, Volume: 77, Issue:7 Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Care Units; Echocardiography; Enalapril; Exercise Test; Follow-Up Studies; Fosinopril; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Stroke Volume; Time Factors; Treatment Outcome	1999
Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure. Circulation, 2000, Feb-29, Volume: 101, Issue:8 Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Fosinopril; Heart Failure; Humans; Lisinopril; Male; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Treatment Failure; Valine; Valsartan	2000
Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors? Journal of hypertension, 2002, Volume: 20, Issue:12 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Captopril; Circadian Rhythm; Dose-Response Relationship, Drug; Enalapril; Endothelin-1; Fosinopril; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Inbred SHR	2002
Ramipril-associated hepatotoxicity. Archives of pathology & laboratory medicine, 2003, Volume: 127, Issue:11 Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Chemical and Drug Induced Liver Injury, Chronic; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis, Intrahepatic; Enalapril; Fosinopril; Humans; Jaundice; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Ramipril	2003
Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors. European journal of pharmacology, 2006, May-10, Volume: 537, Issue:1-3 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Apolipoprotein B-100; Apolipoproteins B; Atherosclerosis; Captopril; Enalapril; Fosinopril; Humans; Hydrogen Peroxide; Hypochlorous Acid; Lipoproteins, LDL; Lisinopril; Oxidation-Reduction; Peroxidase; Ramipril; Recombinant Proteins	2006
Chronic pretreatment of ACEI reduces no-reflow in patients with acute myocardial infarction treated with primary angioplasty. Clinical cardiology, 2007, Volume: 30, Issue:3 Topics: Adult; Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Captopril; Coronary Angiography; Coronary Circulation; Electrocardiography; Enalapril; Female; Fosinopril; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Research Design; Stroke Volume; Time Factors; Treatment Outcome	2007
Spectrophotometric and atomic absorption determination of ramipril, enalapril maleate and fosinopril through ternary complex formation with molybdenum (V)-thiocyanate (Mo(V)-SCN). Chemical & pharmaceutical bulletin, 2008, Volume: 56, Issue:11 Topics: Angiotensin-Converting Enzyme Inhibitors; Chromatography, High Pressure Liquid; Enalapril; Excipients; Fosinopril; Indicators and Reagents; Molybdenum; Ramipril; Spectrophotometry, Atomic; Spectrophotometry, Ultraviolet; Tablets; Thiocyanates	2008
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice. Pharmacological research, 2012, Volume: 65, Issue:3 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anticonvulsants; Captopril; Drug Synergism; Enalapril; Female; Fosinopril; Male; Mice; Motor Activity; Seizures	2012
Angiotensin converting enzyme inhibitors mitigate collagen synthesis induced by a single dose of radiation to the whole thorax. Journal of radiation research, 2012, Volume: 53, Issue:1 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Collagen; Dose-Response Relationship, Radiation; Drug Evaluation, Preclinical; Enalapril; Female; Fibrosis; Fosinopril; Gene Expression Regulation; Lung; Pulmonary Fibrosis; Radiation Pneumonitis; Rats; Renin-Angiotensin System; Thorax	2012
Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitors. International journal of radiation biology, 2014, Volume: 90, Issue:9 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Bone Marrow Transplantation; Calibration; Captopril; Enalapril; Fosinopril; Kidney; Kidney Diseases; Lisinopril; Male; Radiation Injuries; Ramipril; Rats; Renin; Renin-Angiotensin System; Whole-Body Irradiation	2014
Effects of antihypertensive treatment on cardiovascular autonomic control: a prospective study. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2014, Volume: 14, Issue:8 Topics: Antihypertensive Agents; Atenolol; Atrial Fibrillation; Autonomic Nervous System; Cohort Studies; Enalapril; Female; Fosinopril; Humans; Hypertension; Male; Metoprolol; Middle Aged; Prospective Studies	2014
Angiotensin Converting Enzyme Inhibitor Dialyzability and Outcomes in Older Patients Receiving Hemodialysis. Blood purification, 2015, Volume: 40, Issue:3 Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Cardiovascular Diseases; Enalapril; Female; Fosinopril; Hemorheology; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Lisinopril; Male; Middle Aged; Perindopril; Ramipril; Renal Dialysis; Retrospective Studies; Survival Analysis	2015
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010